Ucb Sa Stock Price To Earnings To Growth
| UCBJF Stock | USD 174.00 1.00 0.57% |
UCB SA fundamentals help investors to digest information that contributes to UCB SA's financial success or failures. It also enables traders to predict the movement of UCB Pink Sheet. The fundamental analysis module provides a way to measure UCB SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to UCB SA pink sheet.
UCB |
UCB SA Company Price To Earnings To Growth Analysis
UCB SA's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current UCB SA Price To Earnings To Growth | 6.17 X |
Most of UCB SA's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, UCB SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, UCB SA has a Price To Earnings To Growth of 6.1719 times. This is much higher than that of the Healthcare sector and 96.56% higher than that of the Biotechnology industry. The price to earnings to growth for all United States stocks is 26.21% lower than that of the firm.
Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
UCB Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0468 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 17.07 B | |||
| Shares Outstanding | 189.96 M | |||
| Shares Owned By Insiders | 38.03 % | |||
| Shares Owned By Institutions | 40.78 % | |||
| Price To Earning | 17.62 X | |||
| Price To Book | 1.52 X | |||
| Price To Sales | 2.50 X | |||
| Revenue | 5.78 B | |||
| Gross Profit | 4.34 B | |||
| EBITDA | 1.59 B | |||
| Net Income | 1.06 B | |||
| Cash And Equivalents | 515 M | |||
| Cash Per Share | 2.71 X | |||
| Total Debt | 1.97 B | |||
| Debt To Equity | 0.34 % | |||
| Current Ratio | 1.12 X | |||
| Book Value Per Share | 46.94 X | |||
| Cash Flow From Operations | 1.55 B | |||
| Earnings Per Share | 4.90 X | |||
| Price To Earnings To Growth | 6.17 X | |||
| Number Of Employees | 8.6 K | |||
| Beta | 0.34 | |||
| Market Capitalization | 15.88 B | |||
| Total Asset | 14.21 B | |||
| Retained Earnings | 3 B | |||
| Working Capital | (251 M) | |||
| Current Asset | 2.46 B | |||
| Current Liabilities | 2.71 B | |||
| Z Score | 4.8 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 14.21 B | |||
| Last Dividend Paid | 1.3 |
About UCB SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze UCB SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of UCB SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of UCB SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in UCB Pink Sheet
UCB SA financial ratios help investors to determine whether UCB Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in UCB with respect to the benefits of owning UCB SA security.